Your browser doesn't support javascript.
loading
The Effect of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors on Circulating Endothelial Progenitor Cells in Patients with Cardiovascular Disease.
Itzhaki Ben Zadok, Osnat; Mager, Aviv; Leshem-Lev, Dorit; Lev, Eli; Kornowski, Ran; Eisen, Alon.
Afiliação
  • Itzhaki Ben Zadok O; Department of Cardiology, Rabin Medical Center, 39 Jabotinsky St., 49100, Petah Tikva, Israel. osnat.itzhaki@gmail.com.
  • Mager A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. osnat.itzhaki@gmail.com.
  • Leshem-Lev D; Department of Cardiology, Rabin Medical Center, 39 Jabotinsky St., 49100, Petah Tikva, Israel.
  • Lev E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kornowski R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Eisen A; Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.
Cardiovasc Drugs Ther ; 36(1): 85-92, 2022 02.
Article em En | MEDLINE | ID: mdl-33394363

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Fator A de Crescimento do Endotélio Vascular / Células Progenitoras Endoteliais / Inibidores de PCSK9 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Fator A de Crescimento do Endotélio Vascular / Células Progenitoras Endoteliais / Inibidores de PCSK9 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article